Can this nasal spray slow down Alzheimer's? One couple is helping scientists find out
Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.
Alzheimer's disease
First FDA-cleared Alzheimer's blood test could make diagnoses faster, more accurate
The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and treat the disease.
Latest Alzheimer's lab tests focus on memory loss, not brain plaques
New tests of blood and spinal fluid can identify people experiencing memory loss from Alzheimer's disease.
After an Alzheimer's diagnosis, a new job gave a father 'dignity' and 'purpose'
When Paul Cotter's father began to show signs of early-onset Alzheimer's disease, he lost job after job. Then, a small local company offered him a role that helped rebuild his sense of purpose.
Alzheimer's was taking her memory, so she started taking a new drug
Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.
This metabolic brain boost revives memory in Alzheimer’s mice
An experimental cancer drug that helps the brain turn glucose into energy was able to reverse memory loss in a mouse model of Alzheimer’s disease.
New blood tests can help diagnose Alzheimer's. Are doctors ready for what's next?
A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.
A protein called Reelin keeps popping up in brains that resist aging and Alzheimer’s
Early in life, the protein Reelin helps assemble the brain. Later on, it appears to protect the organ from Alzheimer’s and other threats to memory and thinking.
FDA approves a second Alzheimer's drug that can modestly slow disease
The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.
FDA approves a second Alzheimer's drug that can modestly slow disease
The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.